Enzene is a global CIDMO (Continuously Innovative Development and Manufacturing Organisation) specialising in biologics and biosimilars development, manufacturing and supply. The company is dedicated to helping customers achieve their goals with uncompromised quality, seamless efficiency and reliable cost-effectiveness.
With established sites in India and a strong focus on the USA and Europe, Enzene is expanding into new geographies to offer cost-effective sovereign manufacturing capabilities to companies working with novel molecules. Following the development of a new R&D and manufacturing facility near Princeton, New Jersey, USA, Enzene aims to improve access to manufacturing capabilities for early-stage biological assets.
Enzene’s vision is to transform the landscape of global healthcare with innovative technologies and life-changing treatments. EnzeneX and NeX represent Enzene’s commitment to creating an unparalleled platform for innovation, empowering the delivery of trusted and affordable medicines that enhance quality of life, reshape the pharmaceutical landscape and ultimately make a positive impact on millions of lives worldwide. Together, these innovative platforms are designed to accelerate development, enhance manufacturing capabilities, and create more efficient pathways to bring novel medicines to patients.
Enzene plans to achieve its vision by committing to innovation, quality, scalability, talent, and responsibility.
EnzeneX – Fully-connected continuous manufacturing
EnzeneX is an advanced Fully-Connected Continuous Manufacturing platform that harnesses the power of intensified perfusion using alternating tangential flow (ATF) and automated multi-column chromatography to achieve continuous production of biologics.
Designed for efficiency and cost-effectiveness, EnzeneX® enables uninterrupted loading and processing of materials, delivering superior product quality and manufacturing outcomes.
How can EnzeneX support you?
Cost-Effective Manufacturing
EnzeneX reduces processing costs by approximately 50%, providing you with cost-effective manufacturing. With EnzeneX 2.0, manufacturers can achieve costs as low as $40 per gram of mAb. This is achieved through a lower cost of goods and efficient use of resources.
Increased Productivity
EnzeneX increases manufacturing productivity, achieving approximately 10 times higher productivity than traditional fed-batch manufacturing.
Adaptable Design
EnzeneX provides flexibility with a minimum 30–50 L supply. The modular and variable bioreactors enable scale-on and scale-out flexibility, allowing you to adapt to changing production needs and optimise your manufacturing capacity.
High-Quality Production
EnzeneX minimises product contact with cell culture fluid, ensuring high-quality manufacturing. This is crucial for biologics that are prone to degradation, including less stable and difficult-to-express proteins.
Reduced Emissions
EnzeneX increases sustainability by reducing the equipment footprint and carbon footprint of manufacturing processes.
NeX: Fully-Connected Continuous Manufacturing™ in Your Own Facility
Your dream. Our innovation.
Your autonomy. Our support.
NeX is Enzene’s comprehensive, end-to-end partnership programme that enables governments, institutions and biopharma organisations to establish world-class continuous biomanufacturing within their own territories – faster, fully integrated and with lower capital outlays (compared to conventional fed-batch facilities) for high-yield production.
NeX provides a complete or customisable pathway to local, cost-efficient continuous biomanufacturing in your own facility – including EnzeneX platform facility design, continuous manufacturing technology transfer, operational governance, workforce development through Enzene’s SparX programme and territory-specific pipeline access.
From discovery to commercial supply, an Enzene partnership brings a new way of thinking about biologics. Let’s discuss your next challenge or project.
Meet the Enzene team at Stand #12C57 in Hall 12C during CPHI Milan to find out more about Enzene’s CIDMO capabilities and how Enzene can support your next project.
Book a meeting with Enzene at CPHI Milan:
https://www.enzene.com/events/cphi-milan-2026/
